US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Franklin Genomic Advancements ETF

41.83

+0.23370.56%

Volume:208

Turnover:8.67K

Market Cap:31.37M

PE:- -

High:41.83

Open:41.59

Low:41.83

Close:41.59

52wk High:43.51

52wk Low:29.80

Shares:750.00K

Float Shares:750.00K

Volume Ratio:0.38

T/O Rate:0.03%

Dividend:0.14

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Natera, Inc. : Citigroup Raises Target Price to $365 from $315

THOMSON REUTERS

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Sells 3,000 Shares for $75,000

Natera, Inc. : Stephens Raises Target Price to $350 from $305

THOMSON REUTERS

Natera Partners with Kupando Therapeutics to Use Latitude ctDNA Test in Phase 1 Skin Cancer Trial

Natera to Support New Clinical Trial Assessing Ctdna Dynamics with Latitude™ in Advanced Skin Cancers

THOMSON REUTERS

Natera, Inc. : Piper Sandler Raises Target Price to $363.50 from $249

THOMSON REUTERS

China's Green Fuel Sector Shifts from Pilot Projects to Mass Production

Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares

Goldman Sachs Discloses 2.63% Voting Interest in Qiagen via AFM Filing

Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan

Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative?

Simply Wall St.

RBC Capital Remains a Buy on GH Research (GHRS)

Natera Executive Chairman Matthew Rabinowitz Reports Disposal of 2,000 Common Shares Worth $641,800

Canada's DRI Healthcare Q2 Income Rises, Helped by Milestone Events in Royalty Portfolio

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), AMN Healthcare Services (AMN) and Warby Parker (WRBY)

Natera CEO Says Company Is 'Clearly on a Roll' After Record Test Volumes, Raises Outlook

Benzinga Earnings

Natera up over 19%, on Pace for Record High Close

Ligand Pharmaceuticals (LGND) Posts Strong Q2 Results, Is The Upside Already Priced In?

Simply Wall St.

Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/HELX/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":41.8273,"timestamp":1789502400000,"preClose":41.5936,"halted":0,"volume":208,"delay":0,"changeRate":0.005618652869672231,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"Pre-Mkt","change":0.2337,"latestTime":"09-16 05:37:08 EDT","open":41.5936,"high":41.8273,"low":41.8273,"amount":8673.69984,"amplitude":0,"askPrice":66.5,"askSize":100,"bidPrice":16.82,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"exchange":"CBOE","adjPreClose":41.8273,"sharesOutstanding":650000,"nav":41.622,"aum":31216701.03,"dividendRate":0.003381,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":41.5936,"preClose":41.8273,"latestTime":"19:30 EDT","volume":8,"amount":334.151,"timestamp":1789515006138,"change":-0.2337,"changeRate":-0.005587,"amplitude":0},"volumeRatio":0.38490008114174834,"impliedVol":0.0896,"impliedVolPercentile":0.344},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.38490008114174834,"shares":750000,"dividePrice":0.1414,"high":41.8273,"amplitude":0,"preClose":41.5936,"low":41.8273,"week52Low":29.8,"pbRate":"--","week52High":43.5089,"institutionHeld":0,"latestPrice":41.8273,"eps":0,"divideRate":0.003381,"volume":208,"delay":0,"ttmEps":0,"open":41.5936,"prevYearClose":36.3062,"prevWeekClose":40.9874,"prevMonthClose":41.805,"prevQuarterClose":39.9651,"fiveDayClose":41.6426,"twentyDayClose":41.1366,"sixtyDayClose":35.8162},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659153712","title":"Natera, Inc. : Citigroup Raises Target Price to $365 from $315","url":"https://stock-news.laohu8.com/highlight/detail?id=2659153712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659153712?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:33","pubTimestamp":1786617184,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GNOM","LU0106261612.USD","LU0345770993.USD","LU2065171402.SGD","LU2065169927.USD","LU2264538146.SGD","LU2065171311.SGD","LU0012050646.USD","NTRA","LU2065731478.USD","LU0053671581.USD","LU0963586101.USD","LU2065170008.USD","LU0345770308.USD","LU1064131342.USD","HELX","LU1988902786.USD","LU2324357040.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659189872","title":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Sells 3,000 Shares for $75,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2659189872","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659189872?lang=en_us&edition=fundamental","pubTime":"2026-08-13 07:34","pubTimestamp":1786577651,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky sells 3,000 shares for $75,000Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky sold 3,000 common shares on Aug. 10","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL6LzfyQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Sells 3,000 Shares for $75,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","HELX","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658118976","title":"Natera, Inc. : Stephens Raises Target Price to $350 from $305","url":"https://stock-news.laohu8.com/highlight/detail?id=2658118976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658118976?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:21","pubTimestamp":1786530064,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490FB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HELX","LU0345770308.USD","LU2065169927.USD","LU2065731478.USD","LU0053671581.USD","LU2065171311.SGD","BK4139","LU0106261612.USD","LU2065170008.USD","LU2065171402.SGD","GNOM","LU1988902786.USD","LU0012050646.USD","NTRA","LU2324357040.USD","LU2264538146.SGD","LU0345770993.USD","LU0963586101.USD","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658975282","title":"Natera Partners with Kupando Therapeutics to Use Latitude ctDNA Test in Phase 1 Skin Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658975282","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658975282?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:01","pubTimestamp":1786528893,"startTime":"0","endTime":"0","summary":"Natera partners with Kupando Therapeutics to use Latitude ctDNA test in Phase 1 skin cancer trialNatera entered a collaboration with Kupando Therapeutics to support a Phase 1 trial of immunotherapy ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLbT5KLV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","LU2324357040.USD","BK4139","LU2065170008.USD","LU0963586101.USD","LU2065171402.SGD","LU0012050646.USD","NTRA","HELX","LU1064131342.USD","LU1988902786.USD","LU0345770993.USD","LU2065169927.USD","LU2065171311.SGD","LU0106261612.USD","LU0345770308.USD","LU2264538146.SGD","LU2065731478.USD","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658975416","title":"Natera to Support New Clinical Trial Assessing Ctdna Dynamics with Latitude™ in Advanced Skin Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658975416","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658975416?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:00","pubTimestamp":1786528800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA74PDL6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2264538146.SGD","HELX","LU2065171402.SGD","LU2065171311.SGD","LU0345770993.USD","GNOM","LU2065170008.USD","LU0963586101.USD","LU1064131342.USD","LU2065731478.USD","NTRA","LU0053671581.USD","LU0106261612.USD","LU0012050646.USD","BK4139","LU2065169927.USD","LU0345770308.USD","LU2324357040.USD","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658975588","title":"Natera, Inc. : Piper Sandler Raises Target Price to $363.50 from $249","url":"https://stock-news.laohu8.com/highlight/detail?id=2658975588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658975588?lang=en_us&edition=fundamental","pubTime":"2026-08-12 17:49","pubTimestamp":1786528145,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490C2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU1988902786.USD","LU2065171311.SGD","LU2065170008.USD","LU2065169927.USD","LU0106261612.USD","HELX","GNOM","LU0963586101.USD","LU2065171402.SGD","LU1064131342.USD","BK4139","LU0053671581.USD","LU0345770993.USD","LU0012050646.USD","LU2065731478.USD","LU0345770308.USD","LU2264538146.SGD","NTRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109741990","title":"China's Green Fuel Sector Shifts from Pilot Projects to Mass Production","url":"https://stock-news.laohu8.com/highlight/detail?id=1109741990","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109741990?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:20","pubTimestamp":1786504847,"startTime":"0","endTime":"0","summary":" As global climate governance enters a critical phase, green fuel, a key link between renewable energy and end-use consumption, is transitioning from an \"option\" to a \"necessity.\" Li Zhongwu,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658949165","title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2658949165","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658949165?lang=en_us&edition=fundamental","pubTime":"2026-08-12 06:23","pubTimestamp":1786487005,"startTime":"0","endTime":"0","summary":"Guardant Health Chief Commercial Officer Chris Freeman disposes of $ 10.75 million in common sharesGuardant Health Chief Commercial Officer Chris Freeman exercised stock options for 63,605 shares on A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4khYKk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GNOM","BK4196","GH","GNMX","FFOX","LU0109394709.USD","LU0889565916.HKD","BK4551","BK4588","PTH","EKG","GDOC","LU0320765992.SGD","HELX","BK4535","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658737957","title":"Goldman Sachs Discloses 2.63% Voting Interest in Qiagen via AFM Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658737957","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658737957?lang=en_us&edition=fundamental","pubTime":"2026-08-11 06:36","pubTimestamp":1786401393,"startTime":"0","endTime":"0","summary":"An announcement from Qiagen ( ($QGEN) ) is now available. Qiagen N.V., a Netherlands-based life sciences and molecular diagnostics company headquar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/goldman-sachs-discloses-2-63-voting-interest-in-qiagen-via-afm-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/goldman-sachs-discloses-2-63-voting-interest-in-qiagen-via-afm-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3B42.SGD","LU0251142724.SGD","LU0345770308.USD","HTEC","BK4585","LU0868494617.USD","LU1791807156.HKD","LU0942090050.USD","BK4588","IE00BFXG1179.USD","IE0034235188.USD","LU2471134952.CNY","LU1868837136.USD","BK4516","BK4504","BK4550","LU2237443382.USD","LU1868837300.USD","LU1668664300.SGD","LU1804176565.USD","LU1894683264.USD","LU1868836591.USD","IE00B19Z3581.USD","LU2237443895.HKD","LU1868836757.USD","LU0251131958.USD","BK4552","LU2471134796.USD","IE0004091025.USD","LU0061475181.USD","GSX","BK4533","IE0004086264.USD","GNMX","LU2237443549.SGD","LU2265009873.SGD","IE00BSNM7G36.USD","LU2237443978.SGD","LU2237443622.USD","HELX","GS","BK4127","LU2750360641.GBP","LU0345770993.USD","LU2237443465.HKD","LU1894683348.USD","LU0048573561.USD","LU2237438978.USD","LU2471134879.HKD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658599689","title":"Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2658599689","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658599689?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:13","pubTimestamp":1786392812,"startTime":"0","endTime":"0","summary":"Guardant Health grants 46,044 RSUs to 149 new employees under inducement planGuardant Health set inducement RSU grants covering 46,044 common shares for 149 new non-executive hires, with an Aug. 3, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL208d3j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4585","HELX","LU0109394709.USD","GDOC","BK4535","LU0889565916.HKD","BK4588","GNOM","LU0320765992.SGD","FFOX","GNMX","LFSC","BK4196","EKG","PTH","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658660616","title":"Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658660616","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658660616?lang=en_us&edition=fundamental","pubTime":"2026-08-10 07:38","pubTimestamp":1786318701,"startTime":"0","endTime":"0","summary":"GH Research PLC recently reported second-quarter 2026 results showing a net loss of US$15.15 million, up from US$9.29 million a year earlier, with basic and diluted loss per share from continuing operations rising to US$0.23 from US$0.15.\nFor the first half of 2026, the company’s net loss expanded to US$34.11 million versus US$20.10 million in the prior-year period, highlighting a meaningful increase in cash burn and pressure on its financial profile.\nWe’ll now examine how this widening net...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/is-gh-researchs-rising-loss-per-share-reframing-the-ghrs-cas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/is-gh-researchs-rising-loss-per-share-reframing-the-ghrs-cas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GNMX","BK4007","GDOC","GNOM","HELX","LU0889565916.HKD","BK4539","PTH","BK4585","BK4551","BK4196","LU0320765992.SGD","PSIL","BK4535","LU0109394709.USD","GHRS","BK4588","LFSC","EKG","FFOX","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657229326","title":"RBC Capital Remains a Buy on GH Research (GHRS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657229326","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657229326?lang=en_us&edition=fundamental","pubTime":"2026-08-08 09:45","pubTimestamp":1786153544,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams maintained a Buy rating on GH Research on August 6 and set a price target of $42.00. The company’s shares closed...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-gh-research-ghrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-gh-research-ghrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GHRS","LU0310800379.SGD","LFSC","GNOM","GSIB","BK4196","BK4551","LU0889565916.HKD","PTH","HELX","LU0708994859.HKD","LU0109394709.USD","LU0320765992.SGD","FFOX","BK4588","GNMX","EKG","LU0029864427.USD","BK4539","PSIL","LU1267930573.SGD","BK4207","GDOC","GH","BK4007","BK4535","LU0128525929.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657622568","title":"Natera Executive Chairman Matthew Rabinowitz Reports Disposal of 2,000 Common Shares Worth $641,800","url":"https://stock-news.laohu8.com/highlight/detail?id=2657622568","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657622568?lang=en_us&edition=fundamental","pubTime":"2026-08-08 09:35","pubTimestamp":1786152953,"startTime":"0","endTime":"0","summary":"Natera Executive Chairman Matthew Rabinowitz reports disposal of 2,000 common shares worth $641,800Natera Executive Chairman Matthew Rabinowitz reported a sale of 2,000 common shares on Aug. 7 at USD ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260808:nNDLSJWxn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera Executive Chairman Matthew Rabinowitz Reports Disposal of 2,000 Common Shares Worth $641,800","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","NTRA","LU0012050646.USD","LU2065171311.SGD","LU2324357040.USD","LU0963586101.USD","BK4139","LU0345770308.USD","LU1988902786.USD","LU1064131342.USD","LU2065170008.USD","LU0345770993.USD","LU2264538146.SGD","LU0106261612.USD","LU0053671581.USD","LU2065731478.USD","LU2065171402.SGD","LU2065169927.USD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657629107","title":"Canada's DRI Healthcare Q2 Income Rises, Helped by Milestone Events in Royalty Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2657629107","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657629107?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:12","pubTimestamp":1786137124,"startTime":"0","endTime":"0","summary":"Canada's DRI Healthcare Q2 income rises, helped by milestone events in royalty portfolioOverviewCanada pharmaceutical royalty investor's Q2 total income rose to a record $50.1 mlnAdjusted EBITDA margi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL1N444109:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1559883803.SGD","IE0009354923.USD","LU0566484027.USD","XNCR","IHE","RPRX","BK4139","LGND","PBE","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657260426","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657260426","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657260426?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:30","pubTimestamp":1786134613,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on InMode (INMD), GH Research (GHRS) and Scholar Rock...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-inmode-inmd-gh-research-ghrs-and-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-inmode-inmd-gh-research-ghrs-and-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRN","XLV","PSIL","GHRS","LU0109394709.USD","GH","BK4551","HCSG","BK4082","EKG","LFSC","LU0320765992.SGD","LABU","BK4588","BK4581","FFOX","GNOM","LU0128526141.USD","GDOC","BK4007","THNR","SRRK","BK4535","HELX","BK4585","BK4137","GNMX","LU0029874061.USD","BK4196","INMD","BK4139","LU0889565916.HKD","PTH","BK4539","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657663625","title":"Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), AMN Healthcare Services (AMN) and Warby Parker (WRBY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657663625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657663625?lang=en_us&edition=fundamental","pubTime":"2026-08-08 03:40","pubTimestamp":1786131636,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ligand Pharma (LGND), AMN Healthcare Services (AMN...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ligand-pharma-lgnd-amn-healthcare-services-amn-and-warby-parker-wrby-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ligand-pharma-lgnd-amn-healthcare-services-amn-and-warby-parker-wrby-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","XLV","AMN","LU0566484027.USD","BK4139","BK4581","BK4585","XBI","BK4200","LGND","BK4588","IE0009354923.USD","BK4007","HELX","LU1559883803.SGD","WRBY","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657235366","title":"Natera CEO Says Company Is 'Clearly on a Roll' After Record Test Volumes, Raises Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657235366","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657235366?lang=en_us&edition=fundamental","pubTime":"2026-08-08 02:35","pubTimestamp":1786127721,"startTime":"0","endTime":"0","summary":"Natera stock spikes as strong oncology demand drives record test volumes and a full-year revenue outlook bump.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/08/61052706/natera-ceo-says-company-is-clearly-on-a-roll-after-record-test-volumes-raises-outlook","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","LU0012050646.USD","BK4139","LU0963586101.USD","LU2065171402.SGD","LU0106261612.USD","LU0345770308.USD","GNOM","LU2264538146.SGD","LU2065731478.USD","LU0053671581.USD","HELX","LU2065169927.USD","LU2324357040.USD","LU2065170008.USD","LU1988902786.USD","NTRA","LU1064131342.USD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657362840","title":"Natera up over 19%, on Pace for Record High Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2657362840","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657362840?lang=en_us&edition=fundamental","pubTime":"2026-08-08 01:53","pubTimestamp":1786125180,"startTime":"0","endTime":"0","summary":"Natera, Inc.  is currently at $317.76, up $52.39 or 19.74%--Would be new all-time closing high --On pace for largest percent increase since May 7, 2020, when it rose 21.37%--Snaps a two day losing streak--Up 18.68% this week; best weekly performance since the week ending March 1, 2024, when it rose 26.89%--Up 18.68% month-to-date--Up 38.71% year-to-date--Up 109.12% from 52 weeks ago , when it closed at $151.95--Would be a new 52-week closing high--Up 109.12% from its 52-week closing low of $151.95 on Aug. 8, 2025--Traded as high as $322.00; new all-time intraday high --Up 21.33% at today's intraday high; largest intraday percent increase since Nov. 13, 2024, when it rose as much as 24.18%All data as of 1:50:36 PM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","LU0345770308.USD","LU2324357040.USD","LU2065731478.USD","LU1988902786.USD","HELX","LU0963586101.USD","LU2065171402.SGD","LU2065170008.USD","LU2065169927.USD","BK4139","LU2065171311.SGD","NTRA","LU0106261612.USD","LU2264538146.SGD","LU0012050646.USD","GNOM","LU0053671581.USD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657619974","title":"Ligand Pharmaceuticals (LGND) Posts Strong Q2 Results, Is The Upside Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2657619974","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657619974?lang=en_us&edition=fundamental","pubTime":"2026-08-07 15:37","pubTimestamp":1786088256,"startTime":"0","endTime":"0","summary":"Why Ligand Pharmaceuticals Stock Is Back In Focus After Q2 Results\nLigand Pharmaceuticals (LGND) is back on investor radar after Q2 2026 earnings, a completed royalty acquisition, fresh zero coupon convertible financing, and updated full year guidance released on August 6.\nSee our latest analysis for Ligand Pharmaceuticals.\nThe share price reaction to Ligand Pharmaceuticals' Q2 announcement has been mixed, with a 1 day share price return of a 0.8% decline and a 30 day share price return down...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lgnd/ligand-pharmaceuticals/news/ligand-pharmaceuticals-lgnd-posts-strong-q2-results-is-the-u","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lgnd/ligand-pharmaceuticals/news/ligand-pharmaceuticals-lgnd-posts-strong-q2-results-is-the-u","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","HELX","LU0566484027.USD","IE0009354923.USD","BK4007","LGND","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657369495","title":"Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2657369495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657369495?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:11","pubTimestamp":1786083103,"startTime":"0","endTime":"0","summary":"An update from Oxford BioMedica ( ($GB:OXB) ) is now available. Oxford Biomedica, a specialist cell and gene therapy CDMO, reported around 9% reven...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oxford-biomedica-trims-2026-outlook-but-leans-on-record-client-wins-and-growing-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oxford-biomedica-trims-2026-outlook-but-leans-on-record-client-wins-and-growing-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","GNOM","HELX","IBB","BK4202","WDNA","CNCR","IBBQ","OXM","BK4585","SYNB","JDOC","FBT","LFSC","BK4588","TBXU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}